Açık Akademik Arşiv Sistemi

Browsing by Subject "MULTICENTER"

Browsing by Subject "MULTICENTER"

Sort by: Order: Results:

  • Mortality prediction ability of phycians in intensive care units of Turkey (MOPAP) 
    Pehlivanlar Kucuk, Mehtap; Ozlu, Tevfik; Kucuk, Ahmet Oguzhan; Kaya, Akin; Kirakli, Cenk; Sengoren Dikis, Ozlem; Kefeli Celik, Hale; Ozkan, Serdar; Bektas Aksoy, Hayriye; Palabiyik, Onur; Cortuk, Mustafa; Ergun, Recai; Kozanhan, Betul; Ercen Diken, Ozlem; Bacakoglu, Feza; Uzun Kaya, Suheyla; Aksoy, Iskender; Cinemre, Hakan; Zerman, Avsar; Ozkocak Turan, Isil; Fazlioglu, Nevin; Yildirim, Fatma; Gunay, Ersin; Akan, Belgin; Arpag, Huseyin; Sezgi, Cengizhan; Can, Atilla; Yalcinsoy, Murat; Karaoglanoglu, Selen; Sehitogullari, Abidin; Arslan, Sertac; Aydemir, Yusuf; Ozturk, Ayperi; Hocanli, Iclal; Salmanoglu, Musa; Ekici, Aydanur; Ataman, Sena; Edipoglu, Ozlem; Yildiz, Tekin; Doganay, Zahide; Dagli, Celalettin; Arslan Aksu, Esra; Zitouni, Burcak; Egilez, Ayse Ilksen; Sahiner, Yeliz; Korkmaz Ekren, Pervin (TURKISH ASSOC TUBERCULOSIS & THORAX, 2020)
    Introduction: Intensive care physicians are increasingly involved in decision making about the prognosis of intensive care unit ICU patients. With this study; we aimed to evaluate the power of clinician foresight at ...
  • PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis 
    Ayan, Gizem; Aydin, Sibel Zehra; Kimyon, Gezmis; Ozisler, Cem; Tinazzi, Ilaria; Dogru, Atalay; Omma, Ahmet; Kilic, Levent; Kucuksahin, Orhan; Gonullu, Emel; Can, Meryem; Ylldlz, Fatih; Solmaz, Dilek (OXFORD UNIV PRESS, 2021)
    Objectives. Our aim is to understand clinical characteristics, real-life treatment strategies, outcomes of early PsA patients and determine the differences between the inception and established PsA cohorts. Methods. PsArt-ID ...
  • Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting 
    Altunan, B; Ünal, A; Efendi, H; Köseoglu, M; Terzi, M; Kotan, D; Tamam, Y; Boz, C; Güler, S (2023)
    Background: Follow-on disease modifying therapies (FO-DMTs) do not always require Phase III studies. There are concerns that cheaper FO-DMTs are only used to reduce healthcare costs. However, the well-being of people with ...